My Watchlist Items
- No Watchlist
uniQure N.V. (QURE)
19.18 0.5400009(+2.8970008%)
| Title | Name | Pay | Currency Pay | Gender | Year Born | Title Since |
|---|---|---|---|---|---|---|
| SVice President of R&D and GM of Corlieve | Mr. Richard Porter Ph.D. | N/A | USD | male | N/A | N/A |
| Bus. Devel. Director | Dr. Tamara Tugal Ph.D., MBA | N/A | USD | N/A | N/A | |
| Chief Communications Officer | Ms. Maria E. Cantor | N/A | USD | female | N/A | N/A |
| Chief Legal Officer, Gen. Counsel & Sec. | Mr. David Cerveny | N/A | USD | male | N/A | N/A |
| Chief Operating Officer | Mr. Pierre Caloz | N/A | USD | male | N/A | N/A |
| Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany | Prof. Hugo Katus | N/A | USD | N/A | N/A | |
| Pres of R&D | Dr. Ricardo Dolmetsch Ph.D. | 626150 | USD | 1969 | N/A | |
| Executive Vice President of Quality & Regulatory | Dr. Alexander E. Kuta Ph.D. | 652580 | USD | 1960 | N/A | |
| Chief Financial Officer, Principal Financial Officer & GM of Amsterdam Site | Mr. Christian Klemt | 392600 | USD | male | 1973 | N/A |
| Chief Executive Officer & Executive Director | Mr. Matthew Craig Kapusta | 965480 | USD | male | 1972 | N/A |
| Symbol | Date | Rating | Rating Score | Rating Details |
|---|---|---|---|---|
| QURE | 1 July, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 30 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 29 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 28 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 27 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 24 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 23 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 22 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 21 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 17 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 16 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 15 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 14 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 13 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 10 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 9 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 8 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 7 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 6 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 3 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 2 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 1 June, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 31 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 27 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 26 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 25 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 24 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 23 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 20 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 19 May, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 18 May, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Strong Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Strong Buy) |
| QURE | 17 May, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Strong Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Strong Buy) |
| QURE | 16 May, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Strong Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Strong Buy) |
| QURE | 13 May, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Strong Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Strong Buy) |
| QURE | 12 May, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Strong Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Strong Buy) |
| QURE | 11 May, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Strong Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Strong Buy) |
| QURE | 10 May, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Strong Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Strong Buy) |
| QURE | 9 May, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Strong Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Strong Buy) |
| QURE | 6 May, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Strong Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Strong Buy) |
| QURE | 5 May, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Strong Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Strong Buy) |
| QURE | 4 May, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Strong Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Strong Buy) |
| QURE | 3 May, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Strong Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Strong Buy) |
| QURE | 29 April, 2022 | B | 3 | Rating DCF: (Strong Buy) Rating ROE: (Strong Sell) Rating DCF: (Strong Sell) Rating DE: (Neutral) Rating PE: (Neutral) Rating PB: (Strong Buy) |
| QURE | 28 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 27 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 26 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 25 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 22 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 21 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 20 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 19 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 18 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 14 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 13 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 12 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 11 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 8 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 7 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 6 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 5 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 4 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 1 April, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 31 March, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 30 March, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 29 March, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 28 March, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 25 March, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 24 March, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 23 March, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 22 March, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 21 March, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 18 March, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 17 March, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 16 March, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 15 March, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 14 March, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 11 March, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 10 March, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 9 March, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 8 March, 2022 | A+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Buy) Rating PB: (Strong Buy) |
| QURE | 7 March, 2022 | A | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Buy) Rating PB: (Strong Buy) |
| QURE | 4 March, 2022 | A | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Buy) Rating PB: (Strong Buy) |
| QURE | 3 March, 2022 | A | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Buy) Rating PB: (Strong Buy) |
| QURE | 2 March, 2022 | A | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Buy) Rating PB: (Strong Buy) |
| QURE | 1 March, 2022 | A | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Buy) Rating PB: (Strong Buy) |
| QURE | 28 February, 2022 | A | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Buy) Rating PB: (Strong Buy) |
| QURE | 25 February, 2022 | A | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Buy) Rating PB: (Strong Buy) |
| QURE | 24 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 23 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 22 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 21 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 18 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 17 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 16 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 15 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 14 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 11 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 10 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 9 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| QURE | 8 February, 2022 | B+ | 4 | Rating DCF: (Strong Buy) Rating ROE: (Neutral) Rating DCF: (Neutral) Rating DE: (Neutral) Rating PE: (Strong Sell) Rating PB: (Strong Buy) |
| Holder | Shares | Date Reported | Change |
|---|---|---|---|
| STATE STREET CORP | 2813416 | 31 March, 2022 | 655732 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 330317 | 31 March, 2022 | -1028392 |
| CARLSON CAPITAL L P | 78396 | 31 March, 2022 | 0 |
| FEDERATED HERMES, INC. | 594800 | 31 March, 2022 | -848042 |
| MILLENNIUM MANAGEMENT LLC | 223688 | 31 March, 2022 | -169983 |
| US BANCORP \DE\ | 950 | 31 March, 2022 | 351 |
| INDEXIQ ADVISORS LLC | 23146 | 31 March, 2022 | 21943 |
| BALYASNY ASSET MANAGEMENT LLC | 244487 | 31 March, 2022 | 222942 |
| NISA INVESTMENT ADVISORS, LLC | 4000 | 31 March, 2022 | 1500 |
| TEXAS PERMANENT SCHOOL FUND | 25556 | 31 March, 2022 | -426 |
| AQR CAPITAL MANAGEMENT LLC | 66678 | 31 March, 2022 | 31471 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 26310 | 31 March, 2022 | 26310 |
| WORTH ASSET MANAGEMENT, LLC | 500 | 31 March, 2022 | 500 |
| ALLWORTH FINANCIAL LP | 164 | 31 March, 2022 | 0 |
| EXANE DERIVATIVES | 8 | 31 March, 2022 | 0 |
| LOUISIANA STATE EMPLOYEES RETIREMENT SYSTEM | 17500 | 31 March, 2022 | 100 |
| WELLS FARGO & COMPANY/MN | 20094 | 31 March, 2022 | 4977 |
| SANDERS MORRIS HARRIS LLC | 68070 | 31 March, 2022 | 0 |
| MARYLAND STATE RETIREMENT & PENSION SYSTEM | 14452 | 31 March, 2022 | 312 |
| EVERENCE CAPITAL MANAGEMENT INC | 12780 | 31 March, 2022 | 12780 |
| NORDEA INVESTMENT MANAGEMENT AB | 276375 | 31 March, 2022 | 3594 |
| OPTIMUM INVESTMENT ADVISORS | 300 | 31 March, 2022 | 0 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 700000 | 31 March, 2022 | 100000 |
| BLUEFIN CAPITAL MANAGEMENT, LLC | 54523 | 31 March, 2022 | 54523 |
| HENRY JAMES INTERNATIONAL MANAGEMENT INC. | 125622 | 31 March, 2022 | -30343 |
| COVESTOR LTD | 2790 | 31 March, 2022 | 2790 |
| JEFFERIES GROUP LLC | 28332 | 31 March, 2022 | -4820 |
| JPMORGAN CHASE & CO | 884801 | 31 March, 2022 | 174050 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 29283 | 31 March, 2022 | 0 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 18639 | 31 March, 2022 | 12876 |
| SG3 MANAGEMENT, LLC | 32000 | 31 March, 2022 | 22000 |
| ANFIELD CAPITAL MANAGEMENT, LLC | 546 | 31 March, 2022 | 285 |
| DEUTSCHE BANK AG\ | 102325 | 31 March, 2022 | 50000 |
| SWISS NATIONAL BANK | 82000 | 31 March, 2022 | 5700 |
| UBS GROUP AG | 210180 | 31 March, 2022 | 62551 |
| VOYA INVESTMENT MANAGEMENT LLC | 14439 | 31 March, 2022 | 0 |
| STATE OF WYOMING | 2613 | 31 March, 2022 | 1478 |
| POINT72 ASSET MANAGEMENT, L.P. | 3250300 | 31 March, 2022 | 1284780 |
| ORBIMED ADVISORS LLC | 919249 | 31 March, 2022 | 333675 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 1107 | 31 March, 2022 | -1184 |
| GLOBEFLEX CAPITAL L P | 11131 | 31 March, 2022 | -9239 |
| MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 10756 | 31 March, 2022 | 923 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 14181 | 31 March, 2022 | -58 |
| OREGON PUBLIC EMPLOYEES RETIREMENT FUND | 13423 | 31 March, 2022 | -400 |
| VIRGINIA RETIREMENT SYSTEMS ET AL | 44000 | 31 March, 2022 | 23400 |
| JANE STREET GROUP, LLC | 58528 | 31 March, 2022 | 18446 |
| HARBOR CAPITAL ADVISORS, INC. | 27388 | 31 March, 2022 | -4653 |
| AQUILO CAPITAL MANAGEMENT, LLC | 901490 | 31 March, 2022 | 225284 |
| VIRTUS ETF ADVISERS LLC | 5513 | 31 March, 2022 | -328 |
| AXA S.A. | 83600 | 31 March, 2022 | 73400 |
| PRESTIGE WEALTH MANAGEMENT GROUP LLC | 32 | 31 March, 2022 | 32 |
| PRINCIPAL FINANCIAL GROUP INC | 243006 | 31 March, 2022 | -2458 |
| EQIS CAPITAL MANAGEMENT, INC. | 51118 | 31 March, 2022 | 3902 |
| PDT PARTNERS, LLC | 13606 | 31 March, 2022 | -1663 |
| DEKABANK DEUTSCHE GIROZENTRALE | 39400 | 31 March, 2022 | -3000 |
| BLACKROCK INC. | 4366736 | 31 March, 2022 | 72931 |
| MORGAN STANLEY | 1374166 | 31 March, 2022 | 132418 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 64005 | 31 March, 2022 | 64005 |
| FUTURE FINANCIAL WEALTH MANAGMENT LLC | 2000 | 31 March, 2022 | 0 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 181676 | 31 March, 2022 | 4474 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 2627 | 31 March, 2022 | 368 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | 432 | 31 March, 2022 | -261 |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 92 | 31 March, 2022 | 92 |
| ROYAL BANK OF CANADA | 74770 | 31 March, 2022 | 5328 |
| NUVEEN ASSET MANAGEMENT, LLC | 35847 | 31 March, 2022 | 4967 |
| PARALLAX VOLATILITY ADVISERS, L.P. | 80945 | 31 March, 2022 | 68249 |
| CAPTRUST FINANCIAL ADVISORS | 130 | 31 March, 2022 | -464 |
| COMERICA BANK | 28391 | 31 March, 2022 | -315 |
| RHUMBLINE ADVISERS | 29860 | 31 March, 2022 | 4779 |
| VOSS CAPITAL, LLC | 70000 | 31 March, 2022 | 70000 |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 14300 | 31 March, 2022 | 3400 |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 31076 | 31 March, 2022 | 3839 |
| CAPTION MANAGEMENT, LLC | 17578 | 31 March, 2022 | -223022 |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 114251 | 31 March, 2022 | 36580 |
| STATE OF WISCONSIN INVESTMENT BOARD | 28700 | 31 March, 2022 | 28700 |
| GROUP ONE TRADING, L.P. | 41480 | 31 March, 2022 | -24188 |
| FMR LLC | 3793464 | 31 March, 2022 | -546599 |
| BANK OF MONTREAL /CAN/ | 20249 | 31 March, 2022 | 10341 |
| THRIVENT FINANCIAL FOR LUTHERANS | 61249 | 31 March, 2022 | 17 |
| SIGMA PLANNING CORP | 40676 | 31 March, 2022 | 1384 |
| WINTON GROUP LTD | 67905 | 31 March, 2022 | 19734 |
| STATE OF TENNESSEE, TREASURY DEPARTMENT | 24547 | 31 March, 2022 | 1867 |
| ACADIAN ASSET MANAGEMENT LLC | 109473 | 31 March, 2022 | 98352 |
| TUDOR INVESTMENT CORP ET AL | 23070 | 31 March, 2022 | 23070 |
| PRIVIUM FUND MANAGEMENT B.V. | 493229 | 31 March, 2022 | 23196 |
| ENDURANCE WEALTH MANAGEMENT, INC. | 100 | 31 March, 2022 | 0 |
| VANGUARD GROUP INC | 1209840 | 31 March, 2022 | 30053 |
| INVESCO LTD. | 412982 | 31 March, 2022 | -1961253 |
| KOSHINSKI ASSET MANAGEMENT, INC. | 376 | 31 March, 2022 | 0 |
| NORTHERN TRUST CORP | 126889 | 31 March, 2022 | -5310 |
| TCWP LLC | 97 | 31 March, 2022 | 97 |
| TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | 15500 | 31 March, 2022 | 0 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 63670 | 31 March, 2022 | -2291 |
| BANK OF AMERICA CORP /DE/ | 143665 | 31 March, 2022 | -16801 |
| GOLDMAN SACHS GROUP INC | 302690 | 31 March, 2022 | -13967 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 121212 | 31 March, 2022 | -22451 |
| VONTOBEL HOLDING LTD. | 58136 | 31 March, 2022 | -1598 |
| WALLEYE CAPITAL LLC | 19599 | 31 March, 2022 | 19599 |
| CITIGROUP INC | 154812 | 31 March, 2022 | -29165 |
| BEAIRD HARRIS WEALTH MANAGEMENT, LLC | 152 | 31 March, 2022 | 0 |
| EXCHANGE TRADED CONCEPTS, LLC | 29602 | 31 March, 2022 | 29602 |
| TD ASSET MANAGEMENT INC | 32678 | 31 March, 2022 | 0 |
| ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. | 84905 | 31 March, 2022 | 48828 |
| ATLAS CAPITAL ADVISORS LLC | 811 | 31 March, 2022 | 0 |
| SIMPLEX TRADING, LLC | 16979 | 31 March, 2022 | 16979 |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155500 | 31 March, 2022 | 0 |
| HSBC HOLDINGS PLC | 10705 | 31 March, 2022 | 10705 |
| MEEDER ASSET MANAGEMENT INC | 1513 | 31 March, 2022 | 1513 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 2811459 | 31 March, 2022 | 448146 |
| AMERICAN INTERNATIONAL GROUP, INC. | 2754 | 31 March, 2022 | -7 |
| HANDELSBANKEN FONDER AB | 11800 | 31 March, 2022 | 0 |
| UBS ASSET MANAGEMENT AMERICAS INC | 28320 | 31 March, 2022 | 477 |
| ENSIGN PEAK ADVISORS, INC | 13800 | 31 March, 2022 | 0 |
| PNC FINANCIAL SERVICES GROUP, INC. | 2038 | 31 March, 2022 | 1243 |
| PARKSIDE FINANCIAL BANK & TRUST | 131 | 31 March, 2022 | 0 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 230358 | 31 March, 2022 | 92267 |
| ADVISOR GROUP HOLDINGS, INC. | 8778 | 31 March, 2022 | 479 |
| CREDIT SUISSE AG/ | 26516 | 31 March, 2022 | 1203 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 8610 | 31 March, 2022 | 8610 |
| BANK OF NEW YORK MELLON CORP | 674565 | 31 March, 2022 | -34458 |
| AMERIPRISE FINANCIAL INC | 487619 | 31 March, 2022 | 331509 |
| LEGAL & GENERAL GROUP PLC | 96716 | 31 March, 2022 | -760 |
| SKYVIEW INVESTMENT ADVISORS, LLC | 834 | 31 March, 2022 | 751 |
| PFM HEALTH SCIENCES, LP | 534624 | 31 March, 2022 | 534624 |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | 5194 | 31 March, 2022 | 271 |
| CITADEL ADVISORS LLC | 43734 | 31 March, 2022 | 9426 |
| NINEPOINTTWO CAPITAL LLC | 14356 | 31 March, 2022 | 0 |
| BANQUE PICTET & CIE SA | 79041 | 31 March, 2022 | 3059 |
| AQUATIC CAPITAL MANAGEMENT LLC | 100 | 31 March, 2022 | 100 |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 67450 | 31 March, 2022 | -5950 |
| RAFFERTY ASSET MANAGEMENT, LLC | 190817 | 31 March, 2022 | 42085 |
| CINCTIVE CAPITAL MANAGEMENT LP | 79282 | 31 March, 2022 | 8900 |
| PICTET ASSET MANAGEMENT SA | 118203 | 31 March, 2022 | 32406 |
| ENVESTNET ASSET MANAGEMENT INC | 60334 | 31 March, 2022 | 8479 |
| ASSENAGON ASSET MANAGEMENT S.A. | 448985 | 31 March, 2022 | 448985 |
| SONIC FUND II, L.P. | 50000 | 31 March, 2022 | 0 |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 5688 | 31 March, 2022 | 0 |
| GENEOS WEALTH MANAGEMENT INC. | 96 | 31 March, 2022 | 96 |
| TEKLA CAPITAL MANAGEMENT LLC | 521693 | 31 March, 2022 | 0 |
| RAYMOND JAMES & ASSOCIATES | 23878 | 31 March, 2022 | -13889 |
| MACQUARIE GROUP LTD | 707141 | 31 March, 2022 | 0 |
| 683 CAPITAL MANAGEMENT, LLC | 1355000 | 31 March, 2022 | 101800 |
| CAPITAL ASSET ADVISORY SERVICES LLC | 27607 | 31 March, 2022 | 7528 |
| CUTLER GROUP LP | 16562 | 31 March, 2022 | -8200 |
| GEODE CAPITAL MANAGEMENT, LLC | 356847 | 31 March, 2022 | -7004 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 335000 | 31 March, 2022 | 45000 |
| LAZARD ASSET MANAGEMENT LLC | 10843 | 31 March, 2022 | 7634 |
| BARCLAYS PLC | 23419 | 31 March, 2022 | 20103 |
| ADVISORNET FINANCIAL, INC | 147 | 31 March, 2022 | 147 |
| STATE OF ALASKA, DEPARTMENT OF REVENUE | 25075 | 31 March, 2022 | -440 |
| YOUSIF CAPITAL MANAGEMENT, LLC | 33144 | 31 March, 2022 | -315 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 170000 | 31 March, 2022 | 70000 |
| ALPS ADVISORS INC | 47743 | 31 March, 2022 | -5727 |
| BOENNING & SCATTERGOOD, INC. | 20000 | 31 March, 2022 | 0 |
| DAIWA SECURITIES GROUP INC. | 158 | 31 March, 2022 | 0 |
| VICTORY CAPITAL MANAGEMENT INC | 14992 | 31 March, 2022 | 14992 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 148898 | 31 March, 2022 | -36302 |
| PRUDENTIAL FINANCIAL INC | 34985 | 31 March, 2022 | -677 |
| SG AMERICAS SECURITIES, LLC | 26165 | 31 March, 2022 | -999 |
| AMERICAN CENTURY COMPANIES INC | 217745 | 31 March, 2022 | 46528 |
| ALLIANCEBERNSTEIN L.P. | 327411 | 31 March, 2022 | 189980 |
| SCHONFELD STRATEGIC ADVISORS LLC | 53201 | 31 March, 2022 | -870 |
| Holder | Shares | Date Reported | Weight Percent |
|---|---|---|---|
| TEXAS PERMANENT SCHOOL FUND | 25556 | 31 March, 2022 | N/A |
| Sonic Fund II, L.P. | 50000 | 31 March, 2022 | N/A |
| OREGON PUBLIC EMPLOYEES RETIREMENT FUND | 13423 | 31 March, 2022 | N/A |
| Privium Fund Management B.V. | 493229 | 31 March, 2022 | N/A |
| SPHERA FUNDS MANAGEMENT LTD. | 100000 | 31 December, 2021 | N/A |
| HIGHLAND CAPITAL MANAGEMENT FUND ADVISORS, L.P. | 23311 | 30 September, 2021 | N/A |
| Verition Fund Management LLC | 18334 | 30 September, 2021 | N/A |
| State of New Jersey Common Pension Fund D | 56973 | 31 December, 2020 | N/A |
| iShares NASDAQ Biotechnology ETF | 455155 | 31 August, 2020 | 0.19 |
| iShares NASDAQ US Biotechnology UCITS ETF | 12888 | 31 August, 2020 | 0.2 |
| Fidelity MSCI Health Care Index ETF | 14111 | 31 August, 2020 | 0.03 |
| iShares Ageing Population UCITS ETF | 17455 | 31 August, 2020 | 0.26 |
| Global X Genomics & Biotechnology ETF | 27541 | 31 August, 2020 | 2.07 |
| iShares Genomics Immunology and Healthcare ETF | 49248 | 31 August, 2020 | 1.3 |
| ALPS Medical Breakthroughs ETF | 55746 | 31 August, 2020 | 1.26 |
| iShares Healthcare Innovation UCITS ETF | 142671 | 31 August, 2020 | 0.43 |
| Vanguard Health Care Index Fund | 91626 | 31 August, 2020 | 0.03 |
| CSIF (CH) III Equity World ex CH Small Cap Blue - Pension Fund | 10026 | 31 August, 2020 | 0.02 |
| BNY Mellon Small Cap Multi-Strategy Fund | 46249 | 31 July, 2020 | 0.43 |
| Invesco Oppenheimer Global Fund | 1031900 | 31 July, 2020 | 0.4 |
| Fidelity Growth Company Fund | 792630 | 31 July, 2020 | 0.06 |
| Delaware Healthcare Fund | 706166 | 31 July, 2020 | 2.47 |
| Fidelity Select Biotechnology Portfolio | 670608 | 31 July, 2020 | 0.4 |
| Fidelity Select Health Care Portfolio | 400000 | 31 July, 2020 | 0.19 |
| Fidelity Advisor Biotechnology Fund | 333500 | 31 July, 2020 | 0.6 |
| BNY Mellon Small/Mid Cap Growth Fund | 289312 | 31 July, 2020 | 0.36 |
| Fidelity Advisor Health Care Fund | 254000 | 31 July, 2020 | 0.2 |
| Invesco Oppenheimer VI Global Fund | 235939 | 31 July, 2020 | 0.41 |
| Fidelity Series Growth Company Fund | 178573 | 31 July, 2020 | 0.06 |
| Franklin Templeton Investment Funds -Biotechnology Discovery | 136200 | 31 July, 2020 | 0.33 |
| Swedbank Robur Medica | 136000 | 31 July, 2020 | 0.5 |
| Franklin Biotechnology Discovery Fund | 103300 | 31 July, 2020 | 0.32 |
| Columbia Small Cap Growth Fund I | 100700 | 31 July, 2020 | 0.31 |
| PGIM Jennison Health Sciences Fund | 95788 | 31 July, 2020 | 0.21 |
| Fidelity Growth Company K6 Fund | 86352 | 31 July, 2020 | 0.07 |
| LSP Life Sciences Fund N.V. | 76394 | 31 July, 2020 | 6.54 |
| Fidelity Stock Selector All Cap Fund | 70054 | 31 July, 2020 | 0.03 |
| Invesco Oppenheimer Main Street Small Cap Fund | 69272 | 31 July, 2020 | 0.42 |
| Invesco Oppenheimer VI Main Street Small Cap Fd | 64959 | 31 July, 2020 | 0.43 |
| BNY Mellon Opportunistic Small Cap Fund | 61709 | 31 July, 2020 | 0.65 |
| Lupus Alpha Micro Champions | 56000 | 31 July, 2020 | 2.31 |
| Fidelity VIP Health Care Portfolio | 50000 | 31 July, 2020 | 0.2 |
| Fidelity Select Pharmaceuticals Portfolio | 48900 | 31 July, 2020 | 0.24 |
| BNY Mellon Opportunistic Small Cap Port | 37469 | 31 July, 2020 | 0.64 |
| Transamerica T. Rowe Price Small Cap VP | 35441 | 31 July, 2020 | 0.15 |
| EQ/Oppenheimer Global Portfolio | 32988 | 31 July, 2020 | 0.4 |
| Invesco NASDAQ Biotech UCITS ETF | 31411 | 31 July, 2020 | 0.2 |
| EQ/Global Equity Managed Volatility Portfolio | 30126 | 31 July, 2020 | 0.07 |
| MassMutual Premier Global Fund | 28966 | 31 July, 2020 | 0.4 |
| Columbia Variable Portfolio - Small Company Growth Fund | 27634 | 31 July, 2020 | 0.28 |
| DWS Biotech | 25000 | 31 July, 2020 | 0.21 |
| BNY Mellon Mid Cap Multi-Strategy Fund | 24865 | 31 July, 2020 | 0.04 |
| Fidelity NASDAQ Composite Index Fund | 24750 | 31 July, 2020 | 0.01 |
| MassMutual Premier Small Cap Opportunities Fund | 23307 | 31 July, 2020 | 0.43 |
| Driehaus Small Cap Growth Fund | 16763 | 31 July, 2020 | 0.3 |
| Bellevue Funds (Lux) - BB Adamant Biotech | 13900 | 31 July, 2020 | 0.9 |
| Vanguard Total World Stock Index Fund | 13142 | 31 July, 2020 | N/A |
| Driehaus International Small Cap Growth Fund | 12500 | 31 July, 2020 | 0.21 |
| MML Small Cap Equity Fund | 10809 | 31 July, 2020 | 0.43 |
| Fidelity NASDAQ Composite Index Tracking Stock | 10052 | 31 July, 2020 | 0.01 |
| Espa Stock Biotec | 34000 | 30 June, 2020 | 0.52 |
| Putnam VT Global Health Care Fund | 11000 | 30 June, 2020 | 0.35 |
| Federated Hermes Kaufmann Small Cap Fund | 1110000 | 30 June, 2020 | 0.8 |
| JNL/Mellon Capital Healthcare Sector Fund | 24153 | 30 June, 2020 | 0.03 |
| Federated Hermes Kaufmann Fund | 1870000 | 30 June, 2020 | 1.14 |
| Met Investors Series Trust - Oppenheimer Global Equity Portfolio | 126158 | 30 June, 2020 | N/A |
| Putnam Global Health Care Fund | 108900 | 30 June, 2020 | 0.35 |
| Federated Unit Trust LVM ProFutur | 18029 | 30 June, 2020 | 1.18 |
| T. Rowe Price New Horizons Fund | 269875 | 30 June, 2020 | 0.04 |
| VY Invesco Oppenheimer Global Portfolio | 137113 | 30 June, 2020 | 0.45 |
| DekaLux-BioTech | 17100 | 30 June, 2020 | 0.23 |
| Federated Hermes Intl Small-Mid Company Fd | 14700 | 30 June, 2020 | 0.62 |
| T Rowe Price QM US Small-Cap Growth Equity Fund | 308800 | 30 June, 2020 | 0.17 |
| TD Health Sciences Fund | 14000 | 30 June, 2020 | 0.07 |
| Worldwide Healthcare Trust PLC | 551379 | 30 June, 2020 | 1.06 |
| Royce Smaller-Companies Growth Fund | 54000 | 30 June, 2020 | 1.09 |
| Federated Hermes Kaufmann Fund II | 49300 | 30 June, 2020 | 1.35 |
| JNL/Invesco Global Growth Fund | 231390 | 30 June, 2020 | 0.46 |
| Artisan Global Equity Fund (Ire) | 48105 | 30 June, 2020 | 0.71 |
| Brighthouse Funds Trust II -T. Rowe Price Small Cap Growth Portfolio | 46800 | 30 June, 2020 | 0.16 |
| Osterweis Emerging Opportunity Fund | 43580 | 30 June, 2020 | 1.57 |
| Lord Abbett Securities Trust - Intl Opportunities Fund | 36208 | 30 June, 2020 | 0.41 |
| Artisan Global Equity Fund (US) | 35990 | 30 June, 2020 | 0.71 |
| Vanguard Global Small-Cap Index Fund | 12355 | 30 June, 2020 | 0.03 |
| VALIC Co I Health Sciences Fund | 11600 | 30 June, 2020 | 0.06 |
| Carillon Eagle Small Cap Growth Fund | 260953 | 30 June, 2020 | 0.4 |
| JPMorgan Funds Thematics - Genetic Therapies | 179494 | 31 May, 2020 | 2.44 |
| UBS (Lux) Equity Fund - Biotech (USD) | 248700 | 31 May, 2020 | 1.56 |
| UBS (Lux) Equity SICAV - Long Term Themes (USD) | 624900 | 31 May, 2020 | 1.24 |
| BlackRock Health Sciences Trust II | 127900 | 31 May, 2020 | 0.33 |
| UBS (CH) Inst Fd 2-Eq Global Small Cap Passive II | 11857 | 31 May, 2020 | 0.04 |
| UBS (Lux) Equity Fund - Health Care (USD) | 14800 | 31 May, 2020 | 0.71 |
| New Capital US Small Cap Growth Fund | 17435 | 31 May, 2020 | 1.34 |
| Invesco Global Equity | 11175 | 31 May, 2020 | 0.7 |
| Lord Abbett Micro Cap Growth Fund | 12500 | 30 April, 2020 | 0.65 |
| Janus Henderson Triton Fund | 641311 | 31 March, 2020 | 0.38 |
| Eventide Healthcare & Life Sciences Fund | 500000 | 31 March, 2020 | 2.53 |
| Tekla Healthcare Investors | 24098 | 31 March, 2020 | 0.14 |
| Tekla Life Sciences Investors | 19751 | 31 March, 2020 | 0.26 |
| Pacific Select Developing Growth Portfolio | 19617 | 31 March, 2020 | 0.49 |
| Federated Unit Trust LVM Europa Aktien | 18080 | 31 March, 2020 | 1.1 |
| Federated Unit Trust Inter Aktien LVM | 11897 | 31 March, 2020 | 0.69 |
| MainStay VP Small Cap Growth Portfolio | 32832 | 31 March, 2020 | 0.42 |
| Polar Capital Biotechnology Fund | 100000 | 31 December, 2019 | N/A |
| Quadriga Investors - GFED Aequitas Fund | 18056 | 31 December, 2019 | 10.19 |
| Statens Pensjonsfond Utland | 378092 | 31 December, 2019 | N/A |
| Selectra Investments - J. Lamarck Biotech | 13000 | 31 December, 2019 | 1.17 |
| Salient International Small Cap Fund | 19000 | 31 October, 2019 | N/A |
| Symbol | Transaction Date | Reporting Cik | Securities Owned | Company Cik | Reporting Name | Acquistion Or Disposition | Form Type | Securities Transacted | Security Name | Link |
|---|---|---|---|---|---|---|---|---|---|---|
| QURE | 16 June, 2022 | 0001867944 | 64511 | 0001590560 | CALOZ PIERRE | D | 4 | 7575 | Ordinary Shares | View |
| QURE | 16 June, 2022 | 0001711885 | 104688 | 0001590560 | KLEMT CHRISTIAN | D | 4 | 1687 | Ordinary Shares | View |
| QURE | 15 June, 2022 | 0001772610 | 17810 | 0001590560 | Jacques Rachelle Suzanne | A | 4 | 17810 | Stock Option (Right to Buy) | View |
| QURE | 15 June, 2022 | 0001772610 | 10614 | 0001590560 | Jacques Rachelle Suzanne | A | 4 | 9080 | Ordinary Shares | View |
| QURE | 15 June, 2022 | 0001235862 | 17810 | 0001590560 | POST LEONARD E | A | 4 | 17810 | Stock Option (Right to Buy) | View |
| QURE | 15 June, 2022 | 0001235862 | 12201 | 0001590560 | POST LEONARD E | A | 4 | 9080 | Ordinary Shares | View |
| QURE | 15 June, 2022 | 0001376099 | 17810 | 0001590560 | Kaye Jack | A | 4 | 17810 | Stock Option (Right to Buy) | View |
| QURE | 15 June, 2022 | 0001376099 | 28083 | 0001590560 | Kaye Jack | A | 4 | 9080 | Ordinary Shares | View |
| QURE | 15 June, 2022 | 0001716268 | 17810 | 0001590560 | Gut Robert | A | 4 | 17810 | Stock Option (Right to Buy) | View |
| QURE | 15 June, 2022 | 0001716268 | 44165 | 0001590560 | Gut Robert | A | 4 | 9080 | Ordinary Shares | View |
| QURE | 15 June, 2022 | 0001692444 | 17810 | 0001590560 | Soteropoulos Paula | A | 4 | 17810 | Stock Option (Right to Buy) | View |
| QURE | 15 June, 2022 | 0001692444 | 16382 | 0001590560 | Soteropoulos Paula | A | 4 | 9080 | Ordinary Shares | View |
| QURE | 15 June, 2022 | 0001555508 | 17810 | 0001590560 | Balachandran Madhavan | A | 4 | 17810 | Stock Option (Right to Buy) | View |
| QURE | 15 June, 2022 | 0001555508 | 19957 | 0001590560 | Balachandran Madhavan | A | 4 | 9080 | Ordinary Shares | View |
| QURE | 15 June, 2022 | 0001717852 | 17810 | 0001590560 | Springhorn Jeremy P. | A | 4 | 17810 | Stock Option (Right to Buy) | View |
| QURE | 15 June, 2022 | 0001717852 | 19957 | 0001590560 | Springhorn Jeremy P. | A | 4 | 9080 | Ordinary Shares | View |
| QURE | 15 June, 2022 | 0001555337 | 17810 | 0001590560 | Meek David D. | A | 4 | 17810 | Stock Option (Right to Buy) | View |
| QURE | 15 June, 2022 | 0001555337 | 16460 | 0001590560 | Meek David D. | A | 4 | 9080 | Ordinary Shares | View |
| QURE | 28 February, 2022 | 0001235862 | 3121 | 0001590560 | POST LEONARD E | D | 4 | 795 | Ordinary Shares | View |
| QURE | 28 February, 2022 | 0001717852 | 10877 | 0001590560 | Springhorn Jeremy P. | D | 4 | 602 | Ordinary Shares | View |
| QURE | 28 February, 2022 | 0001376099 | 19003 | 0001590560 | Kaye Jack | D | 4 | 600 | Ordinary Shares | View |
| QURE | 28 February, 2022 | 0001555508 | 10877 | 0001590560 | Balachandran Madhavan | D | 4 | 602 | Ordinary Shares | View |
| QURE | 28 February, 2022 | 0001555337 | 7380 | 0001590560 | Meek David D. | D | 4 | 602 | Ordinary Shares | View |
| QURE | 28 February, 2022 | 0001692444 | 7302 | 0001590560 | Soteropoulos Paula | D | 4 | 596 | Ordinary Shares | View |
| QURE | 28 February, 2022 | 0001536290 | 360554 | 0001590560 | Kapusta Matthew C | D | 4 | 10195 | Ordinary Shares | View |
| QURE | 28 February, 2022 | 0001711885 | 106375 | 0001590560 | KLEMT CHRISTIAN | D | 4 | 4075 | Ordinary Shares | View |
| QURE | 28 February, 2022 | 0001825206 | 122325 | 0001590560 | Dolmetsch Ricardo | D | 4 | 1484 | Ordinary Shares | View |
| QURE | 28 February, 2022 | 0001716268 | 35085 | 0001590560 | Gut Robert | D | 4 | 1602 | Ordinary Shares | View |
| QURE | 28 February, 2022 | 0001696698 | 95156 | 0001590560 | Kuta Alexander Edward III | D | 4 | 3405 | Ordinary Shares | View |
| QURE | 24 February, 2022 | 0001235862 | 2645 | 0001590560 | POST LEONARD E | A | 4 | 2645 | Stock Option (Right to Buy) | View |
| QURE | 24 February, 2022 | 0001235862 | 3916 | 0001590560 | POST LEONARD E | A | 4 | 1534 | Ordinary Shares | View |
| QURE | 24 February, 2022 | 0001376099 | 2645 | 0001590560 | Kaye Jack | A | 4 | 2645 | Stock Option (Right to Buy) | View |
| QURE | 24 February, 2022 | 0001376099 | 19603 | 0001590560 | Kaye Jack | A | 4 | 1534 | Ordinary Shares | View |
| QURE | 24 February, 2022 | 0001555337 | 2645 | 0001590560 | Meek David D. | A | 4 | 2645 | Stock Option (Right to Buy) | View |
| QURE | 24 February, 2022 | 0001555337 | 7982 | 0001590560 | Meek David D. | A | 4 | 1534 | Ordinary Shares | View |
| QURE | 24 February, 2022 | 0001717852 | 2645 | 0001590560 | Springhorn Jeremy P. | A | 4 | 2645 | Stock Option (Right to Buy) | View |
| QURE | 24 February, 2022 | 0001717852 | 11479 | 0001590560 | Springhorn Jeremy P. | A | 4 | 1534 | Ordinary Shares | View |
| QURE | 24 February, 2022 | 0001555508 | 2645 | 0001590560 | Balachandran Madhavan | A | 4 | 2645 | Stock Option (Right to Buy) | View |
| QURE | 24 February, 2022 | 0001555508 | 11479 | 0001590560 | Balachandran Madhavan | A | 4 | 1534 | Ordinary Shares | View |
| QURE | 24 February, 2022 | 0001692444 | 2645 | 0001590560 | Soteropoulos Paula | A | 4 | 2645 | Stock Option (Right to Buy) | View |
| QURE | 24 February, 2022 | 0001692444 | 7898 | 0001590560 | Soteropoulos Paula | A | 4 | 1534 | Ordinary Shares | View |
| QURE | 24 February, 2022 | 0001772610 | 2645 | 0001590560 | Jacques Rachelle Suzanne | A | 4 | 2645 | Stock Option (Right to Buy) | View |
| QURE | 24 February, 2022 | 0001772610 | 1534 | 0001590560 | Jacques Rachelle Suzanne | A | 4 | 1534 | Ordinary Shares | View |
| QURE | 24 February, 2022 | 0001825206 | 94281 | 0001590560 | Dolmetsch Ricardo | A | 4 | 94281 | Stock Option (Right to Buy) | View |
| QURE | 24 February, 2022 | 0001825206 | 123809 | 0001590560 | Dolmetsch Ricardo | A | 4 | 54683 | Ordinary Shares | View |
| QURE | 24 February, 2022 | 0001696698 | 60179 | 0001590560 | Kuta Alexander Edward III | A | 4 | 60179 | Stock Option (Right to Buy) | View |
| QURE | 24 February, 2022 | 0001696698 | 98601 | 0001590560 | Kuta Alexander Edward III | A | 4 | 34904 | Ordinary Shares | View |
| QURE | 24 February, 2022 | 0001867944 | 63941 | 0001590560 | CALOZ PIERRE | A | 4 | 63941 | Stock Option (Right to Buy) | View |
| QURE | 24 February, 2022 | 0001867944 | 72086 | 0001590560 | CALOZ PIERRE | A | 4 | 37086 | Ordinary Shares | View |
| QURE | 24 February, 2022 | 0001711885 | 75224 | 0001590560 | KLEMT CHRISTIAN | A | 4 | 75224 | Stock Option (Right to Buy) | View |
| QURE | 24 February, 2022 | 0001711885 | 110450 | 0001590560 | KLEMT CHRISTIAN | A | 4 | 43630 | Ordinary Shares | View |
| QURE | 24 February, 2022 | 0001536290 | 215643 | 0001590560 | Kapusta Matthew C | A | 4 | 215643 | Stock Option (Right to Buy) | View |
| QURE | 24 February, 2022 | 0001536290 | 370749 | 0001590560 | Kapusta Matthew C | A | 4 | 125073 | Ordinary Shares | View |
| QURE | 24 February, 2022 | 0001716268 | 2645 | 0001590560 | Gut Robert | A | 4 | 2645 | Stock Option (Right to Buy) | View |
| QURE | 24 February, 2022 | 0001716268 | 36687 | 0001590560 | Gut Robert | A | 4 | 1534 | Ordinary Shares | View |
| QURE | 26 January, 2022 | 0001716268 | 35153 | 0001590560 | Gut Robert | D | 4 | 2348 | Ordinary Shares | View |
| QURE | 26 January, 2022 | 0001696698 | 63697 | 0001590560 | Kuta Alexander Edward III | D | 4 | 2945 | Ordinary Shares | View |
| QURE | 26 January, 2022 | 0001711885 | 66820 | 0001590560 | KLEMT CHRISTIAN | D | 4 | 3963 | Ordinary Shares | View |
| QURE | 26 January, 2022 | 0001536290 | 245676 | 0001590560 | Kapusta Matthew C | D | 4 | 10901 | Ordinary Shares | View |
| QURE | 15 December, 2021 | 0001696698 | 44000 | 0001590560 | Kuta Alexander Edward III | D | 4 | 6000 | Stock Option (Right to Buy) | View |
| QURE | 15 December, 2021 | 0001696698 | 66642 | 0001590560 | Kuta Alexander Edward III | D | 4 | 6000 | Ordinary Shares | View |
| QURE | 15 December, 2021 | 0001696698 | 72642 | 0001590560 | Kuta Alexander Edward III | A | 4 | 6000 | Ordinary Shares | View |
| QURE | 15 November, 2021 | 0001696698 | 50000 | 0001590560 | Kuta Alexander Edward III | D | 4 | 6000 | Stock Option (Right to Buy) | View |
| QURE | 15 November, 2021 | 0001696698 | 66642 | 0001590560 | Kuta Alexander Edward III | D | 4 | 6000 | Ordinary Shares | View |
| QURE | 15 November, 2021 | 0001696698 | 72642 | 0001590560 | Kuta Alexander Edward III | A | 4 | 6000 | Ordinary Shares | View |
| QURE | 21 October, 2021 | 0001772610 | 10000 | 0001590560 | Jacques Rachelle Suzanne | A | 4 | 10000 | Stock Option (Right to Buy) | View |
| QURE | 15 October, 2021 | 0001696698 | 56000 | 0001590560 | Kuta Alexander Edward III | D | 4 | 6000 | Stock Option (Right to Buy) | View |
| QURE | 15 October, 2021 | 0001696698 | 66642 | 0001590560 | Kuta Alexander Edward III | D | 4 | 6000 | Ordinary Shares | View |
| QURE | 15 October, 2021 | 0001696698 | 72642 | 0001590560 | Kuta Alexander Edward III | A | 4 | 6000 | Ordinary Shares | View |
| QURE | 21 September, 2021 | 0001711885 | 70783 | 0001590560 | KLEMT CHRISTIAN | D | 4 | 2400 | Ordinary Shares | View |
| QURE | 21 September, 2021 | 0001716268 | 37501 | 0001590560 | Gut Robert | D | 4 | 4500 | Ordinary Shares | View |
| QURE | 21 September, 2021 | 0001696698 | 66642 | 0001590560 | Kuta Alexander Edward III | D | 4 | 2229 | Ordinary Shares | View |
| QURE | 16 September, 2021 | 0001825206 | 69126 | 0001590560 | Dolmetsch Ricardo | D | 4 | 8603 | Ordinary Shares | View |
| QURE | 15 September, 2021 | 0001696698 | 74871 | 0001590560 | Kuta Alexander Edward III | A | 4 | 6000 | Ordinary Shares | View |
| QURE | 15 September, 2021 | 0001696698 | 62000 | 0001590560 | Kuta Alexander Edward III | D | 4 | 6000 | Stock Option (Right to Buy) | View |
| QURE | 15 September, 2021 | 0001696698 | 74871 | 0001590560 | Kuta Alexander Edward III | A | 4 | 6000 | Stock Option (Right to Buy) | View |
| QURE | 15 September, 2021 | 0001696698 | 68871 | 0001590560 | Kuta Alexander Edward III | D | 4 | 6000 | Ordinary Shares | View |
| QURE | 15 September, 2021 | 0001696698 | 68871 | 0001590560 | Kuta Alexander Edward III | D | 4 | 6000 | Stock Option (Right to Buy) | View |
| QURE | 18 August, 2021 | 0001536290 | 256577 | 0001590560 | Kapusta Matthew C | D | 4 | 117 | Ordinary Shares | View |
| QURE | 18 August, 2021 | 0001536290 | 256694 | 0001590560 | Kapusta Matthew C | D | 4 | 883 | Ordinary Shares | View |
| QURE | 16 August, 2021 | 0001696698 | 74871 | 0001590560 | Kuta Alexander Edward III | A | 4 | 6000 | Ordinary Shares | View |
| QURE | 16 August, 2021 | 0001696698 | 68871 | 0001590560 | Kuta Alexander Edward III | D | 4 | 6000 | Ordinary Shares | View |
| QURE | 16 August, 2021 | 0001696698 | 68000 | 0001590560 | Kuta Alexander Edward III | D | 4 | 6000 | Stock Option (Right to Buy) | View |
| QURE | 15 July, 2021 | 0001696698 | 74000 | 0001590560 | Kuta Alexander Edward III | D | 4 | 6000 | Stock Option (Right to Buy) | View |
| QURE | 15 July, 2021 | 0001696698 | 74871 | 0001590560 | Kuta Alexander Edward III | A | 4 | 6000 | Ordinary Shares | View |
| QURE | 15 July, 2021 | 0001696698 | 68871 | 0001590560 | Kuta Alexander Edward III | D | 4 | 6000 | Ordinary Shares | View |
| QURE | 14 July, 2021 | 0001536290 | 257577 | 0001590560 | Kapusta Matthew C | D | 4 | 1000 | Ordinary Shares | View |
| QURE | 17 June, 2021 | 0001536290 | 258577 | 0001590560 | Kapusta Matthew C | D | 4 | 1900 | Ordinary Shares | View |
| QURE | 16 June, 2021 | 0001536290 | 262470 | 0001590560 | Kapusta Matthew C | D | 4 | 1457 | Ordinary Shares | View |
| QURE | 16 June, 2021 | 0001536290 | 260477 | 0001590560 | Kapusta Matthew C | D | 4 | 1993 | Ordinary Shares | View |
| QURE | 15 June, 2021 | 0001696698 | 74871 | 0001590560 | Kuta Alexander Edward III | A | 4 | 6000 | Ordinary Shares | View |
| QURE | 15 June, 2021 | 0001696698 | 68871 | 0001590560 | Kuta Alexander Edward III | D | 4 | 6000 | Ordinary Shares | View |
| QURE | 15 June, 2021 | 0001696698 | 80000 | 0001590560 | Kuta Alexander Edward III | D | 4 | 6000 | Stock Option (Right to Buy) | View |
| QURE | 15 June, 2021 | 0001711885 | 73183 | 0001590560 | KLEMT CHRISTIAN | A | 4 | 9579 | Ordinary Shares | View |
| QURE | 15 June, 2021 | 0001711885 | 16235 | 0001590560 | KLEMT CHRISTIAN | A | 4 | 16235 | Stock Option (Right to Buy) | View |
| QURE | 15 June, 2021 | 0001867944 | 10000 | 0001590560 | CALOZ PIERRE | A | 4 | 10000 | Stock option (Right to Buy) | View |
| QURE | 15 June, 2021 | 0001867944 | 35000 | 0001590560 | CALOZ PIERRE | A | 4 | 25000 | Ordinary Shares | View |
| QURE | 15 June, 2021 | 0001867944 | 75000 | 0001590560 | CALOZ PIERRE | A | 4 | 75000 | Stock option (Right to Buy) | View |
| QURE | 17 May, 2021 | 0001696698 | 74871 | 0001590560 | Kuta Alexander Edward III | A | 4 | 6000 | Ordinary Shares | View |
| QURE | 17 May, 2021 | 0001696698 | 86000 | 0001590560 | Kuta Alexander Edward III | D | 4 | 6000 | Stock Option (Right to Buy) | View |
| Symbol | Date | Period | Download XLSX File |
|---|---|---|---|
| QURE | 2020 | FY | Download XLSX File |
| QURE | 2019 | FY | Download XLSX File |
| QURE | 2018 | FY | Download XLSX File |
| QURE | 2017 | FY | Download XLSX File |
| QURE | 2016 | FY | Download XLSX File |
| QURE | 2021 | Q3 | Download XLSX File |
| QURE | 2021 | Q1 | Download XLSX File |
| QURE | 2021 | Q2 | Download XLSX File |
| QURE | 2020 | Q1 | Download XLSX File |
| QURE | 2020 | Q4 | Download XLSX File |
| QURE | 2020 | Q3 | Download XLSX File |
| QURE | 2020 | Q2 | Download XLSX File |
| QURE | 2019 | Q2 | Download XLSX File |
| QURE | 2019 | Q1 | Download XLSX File |
| QURE | 2019 | Q3 | Download XLSX File |
| QURE | 2019 | Q4 | Download XLSX File |
| QURE | 2018 | Q1 | Download XLSX File |
| QURE | 2018 | Q3 | Download XLSX File |
| QURE | 2018 | Q4 | Download XLSX File |
| QURE | 2018 | Q2 | Download XLSX File |
| QURE | 2017 | Q2 | Download XLSX File |
| QURE | 2017 | Q1 | Download XLSX File |
| QURE | 2017 | Q4 | Download XLSX File |
| QURE | 2017 | Q3 | Download XLSX File |
| QURE | 2016 | Q4 | Download XLSX File |
Charts
Company Historical Earnings
| Date | Symbol | EPS | EPS Estimated | Time | Revenue | Revenue Estimated |
|---|---|---|---|---|---|---|
| 25 July, 2022 | QURE | bmo | 0 | 10190000 | ||
| 2 May, 2022 | QURE | -1 | -1 | bmo | 1792000000 | 0 |
| 25 February, 2022 | QURE | 0.18 | 0.18 | bmo | 57691000 | 27560000 |
| 25 October, 2021 | QURE | -0.79 | -0.79 | bmo | 1989000 | 2520000 |
| 26 July, 2021 | QURE | 8.51 | 8.51 | bmo | 463868000 | 2520000 |
| 10 May, 2021 | QURE | -0.91 | -0.91 | bmo | 454000 | 438522 |
| 1 March, 2021 | QURE | -0.01 | -0.01 | bmo | 34086000 | 0 |
| 27 October, 2020 | QURE | -1.21 | -1.21 | bmo | 1789000 | 2676107.4380165 |
| 30 July, 2020 | QURE | -0.96 | -0.96 | bmo | 1535000 | 1071302.0833333 |
| 29 April, 2020 | QURE | -0.63 | -0.63 | bmo | 104000 | 138666.66666667 |
| 2 March, 2020 | QURE | -0.96 | -0.96 | bmo | 2625000 | 79083.333333333 |
| 28 October, 2019 | QURE | -0.58 | -0.58 | bmo | 1046000 | 1460793.1034483 |
| 29 July, 2019 | QURE | -0.83 | -0.83 | bmo | 2474000 | 2235542.1686747 |
| 29 April, 2019 | QURE | -0.74 | -0.74 | bmo | 1136000 | 1089945.9459459 |
| 28 February, 2019 | QURE | -0.59 | -0.59 | bmo | 1608000 | 1798779.6610169 |
| 6 November, 2018 | QURE | -0.59 | -0.59 | bmo | 3148000 | 3308067.7966102 |
| 8 August, 2018 | QURE | -0.57 | -0.57 | bmo | 3050000 | 3264035.0877193 |
| 30 April, 2018 | QURE | -0.59 | -0.59 | bmo | 3478000 | 4362237.2881356 |
| 14 March, 2018 | QURE | -0.91 | -0.91 | bmo | 2584000 | 2942923.0769231 |
| 1 November, 2017 | QURE | -0.4 | -0.4 | bmo | 2260000 | 3559500 |
| 8 August, 2017 | QURE | -0.83 | -0.83 | bmo | 4942000 | 4703831.3253012 |
| 9 May, 2017 | QURE | -0.8 | -0.8 | bmo | 3321000 | 2739825 |
| 15 March, 2017 | QURE | -0.54 | -0.54 | bmo | 9045002.333513 | 0 |
| 22 November, 2016 | QURE | -0.61 | -0.61 | bmo | 7254083.64746 | 9240320 |
| 25 August, 2016 | QURE | -0.85 | -0.85 | bmo | 4383710.970957 | 4533155 |
| 31 May, 2016 | QURE | -0.94 | -0.94 | bmo | 4422231.288816 | 3712490 |
| 4 April, 2016 | QURE | -0.63 | -0.63 | bmo | 4422231.288816 | 4806773 |
| 30 November, 2015 | QURE | -1.21 | -1.21 | bmo | 3544383.558561 | 3223296.28125 |
| 27 August, 2015 | QURE | -0.97 | -0.97 | bmo | 1811391.013706 | 6135675 |
| 11 June, 2015 | QURE | -0.74 | -0.74 | bmo | 1198791.462266 | 0 |
| 6 April, 2015 | QURE | -0.64 | -0.64 | bmo | 1198791.462266 | 1027535 |
| 1 December, 2014 | QURE | -0.54 | -0.54 | bmo | 1270175.616689 | 0 |
| 2 September, 2014 | QURE | -0.51 | -0.51 | bmo | 1421594.040765 | 0 |
| 6 June, 2014 | QURE | -0.71 | -0.71 | bmo | 1609132.16889 | 0 |
Company Profile
Company Name uniQure N.V.
Symbol QURE
Currency USD
Price 19.18
Exchange Name NASDAQ Global Select (NASDAQ)
Industry Biotechnology
Website https://www.uniqure.com
CEO Mr. Matthew Craig Kapusta
Sector Healthcare
Country NL
Full Time Employees 463
Phone 31202406000
Address Paasheuvelweg 25a
City AMSTERDAM
State NOORD-HOLLAND
Zip 1105 BP
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-210, a product candidate for the treatment of Parkinson's disease; AMT-260 for temporal lobe epilepsy; AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzheimer's disease; and AMT-161 for the treatment of amyotrophic lateral sclerosis. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
